|Articles|September 27, 2012

Supplements and Featured Publications

  • Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Re
  • Volume 18
  • Issue 8 Suppl

Appendix: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

Download PDF: Appendix: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

Articles in this issue

over 13 years ago

Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

over 13 years ago

Participating Faculty: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text